Surgery

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Lucey, MD

There are a lot of considerations to keep in mind when it comes to liver transplantation in patients with various diseases, like metabolic-associated stereotactic liver diseases, alcoholic liver disease, hepatitis B and C, and more. Joining Dr. Peter Buch to discuss those key considerations surrounding liver transplantation is Dr. Michael Lucey, Professor of Medicine at the University of Wisconsin School of Medicine and Public Health.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Talan, MD

Until recently, surgery was always utilized for appendicitis, but now, antibiotics are an alternative treatment. Find out who the best candidates are for an antibiotic regimen, the efficacy and safety of this approach to treating acute uncomplicated appendicitis, and more with Dr. Peter Buch and Dr. David Talan, Professor of Medicine at UCLA Geffen School of Medicine.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Liska, MD

Since the 1990s, clinicians have been seeing a significant increase in colorectal cancer among young patients, who are under the age of 50. A multidisciplinary approach is key as diagnostic and treatment considerations are specific to their age. Dive in with Dr. Peter Buch as he’s joined by Dr. David Liska, Section Chief of Oncology in the Department of Colorectal Surgery at the Cleveland Clinic.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Alan Bonder, MD

According to the United Network for Organ Sharing (UNOS), more than 95 percent of patients are alive and doing well after a liver transplant. So what else can we learn from UNOS? Join Dr. Peter Buch as he speaks with Dr. Alan Bonder, Assistant Professor of Medicine at Harvard Medical School.

Host: Jennifer Caudle, DO
Guest: Michelle Kincaid, MD

The largest study to date on 4F-PCC was conducted as an FDA postmarketing requirement in partnership between Kaiser Permanente and CSL Behring. The purpose of this long-term study was to compare the 45-day risk of thromboembolic events and all-cause mortality in adults with warfarin-associated major bleeding after treatment with KCENTRA^®, Prothrombin Complex Concentrate (Human), or plasma. Take a deep dive into the data with Dr. Jennifer Caudle as she speaks with Dr. Michelle Kincaid, Trauma Surgeon and Director of Surgical Critical Care at Ohio Health Grant Medical Center in Columbus.

Host: Jennifer Caudle, DO
Guest: Jeran Wadlow
Guest: Josh Elmassian, MBA

Allergan Medical Institute^® has taken a personalized approach to training HCPs in medical aesthetics with the launch of AMI Online. Discover multiple online courses spanning the Allergan Aesthetics portfolio, including content on JUVÉDERM^® VOLUX^® XC. Experience how AMI Online’s evidence-based and progressive training curricula can educate and empower the aesthetics community. Join Dr Jennifer Caudle as she speaks with Jeran Wadlow, Associate Director, Digital at Allergan Medical Institute^® in Irvine, California, and Josh Elmassian, Director of JUVÉDERM^® US Commercial Business and Marketing at Allergan Aesthetics, in Irvine, California.

© 2023 AbbVie. All rights reserved.
JUVÉDERM and its design are trademarks of Allergan Holdings France SAS, an AbbVie company, or its affiliates. All other trademarks are the property of their respective owners.

PRT162857 06/23

Host: Mark Socinski, MD

Host: Jason J. Luke, MD, FACP
Guest: Tara C. Mitchell, MD

The 5-year recurrence rates for stage IIB and IIC melanoma are up to 46%, but now new immunotherapy options are FDA-approved for the adjuvant treatment of stage IIB and IIC melanoma. Find out why this matters and hear Drs. Jason Luke and Tara Mitchell break down the latest data on treating stage IIB and IIC melanoma with adjuvant immunotherapy.

Host: Javed Butler, MD, MBA, MPH
Guest: Pedro A Villablanca Spinetto, MD

A complex condition known as tricuspid valve regurgitation may cause concern for patients as it typically doesn’t show signs or symptoms until the disease is severe. So what technologies and therapies do we have to look forward to? Join Dr. Javed Butler as he speaks with Dr. Pedro Villablanca, Structural Heart Interventional Cardiologist at Henry Ford Health.

Host: Richard S. Finn, MD

Evidence supports the notion that adding targeted agents that have a different mechanism of action than those that cause estrogen receptor interference can improve the benefits and outcomes seen with endocrine therapies alone in HR+/HER2- metastatic breast cancer (mBC). Clinical trial and real-world evidence show that CDK 4/6 inhibitors are safe and effective treatments for HR+/HER2- mBC. Real-world evidence can supplement clinical trial evidence and be more applicable to relevant community-based populations and clinical practice settings.

Optimal care of mBC involves the use of effective therapies that are supported by the latest evidence and guidelines, selected through a shared decision-making process, and individualized to each patient’s needs. The educational Oncology Clinic features an up-to-date review of real-world evidence surrounding CDK 4/6 inhibitors in mBC that expands on available clinical trial evidence. Through case vignettes that model best practices in shared decision-making, expert faculty will demonstrate how to translate clinical trial and real-world evidence into discussions with patients.

Guest: Lisa Parks, MS, APRN-CNP, ANP-BC

When considering prehabilitation for cancer patients about to undergo surgery, what factors should we keep in mind? Nurse Practitioner Lisa Parks from the Ohio State University Wexner Medical Center in Columbus, Ohio explores some of the key considerations involved in prehabilitation.

Guest: Lisa Parks, MS, APRN-CNP, ANP-BC

For some cancer patients undergoing surgery, prehabilitation care could impact their outcomes. So what do nurses need to consider in their preoperative assessment? And what key players are part of the multidisciplinary healthcare team? Lisa Parks from the Ohio State University Wexner Medical Center in Columbus, Ohio explores key factors for cancer surgery.

Guest: Lisa Parks, MS, APRN-CNP, ANP-BC

To learn more about key considerations for prehabilitation, Nurse Practitioner Lisa Parks from the Ohio State University Wexner Medical Center in Columbus, Ohio recaps important factors to keep in mind for cancer patients undergoing surgery.

Host: John Russell, MD
Guest: Stanton Miller, MD, MPH, FACS

Patients who live in an environment impacted by gun violence may face lifelong challenges. But addressing gun violence from a public health standpoint may help clinicians manage the biological, behavioral, and social aspects of this disease. Dr. John Russell is joined by Dr. Stan Miller from the Jefferson Center for Injury Research & Prevention to discuss how clinicians can reframe their approach.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Koji Hashimoto, MD, PhD

What facts should we keep in mind when considering liver transplantation? And how do we determine which of our patients are the right candidates? Dr. Peter Buch explores important considerations for liver transplantation with Dr. Koji Hashimoto, the Director of Liver Transplantation at the Cleveland Clinic.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Benjamin L. Cohen, MD
Guest: Stefan Holubar, MD, MS

New data suggests that the use of anti-TNF therapy early in the treatment course can be effective for patients with inflammatory bowel disease (IBD). However, some of them may still require surgery. But is anti-TNF therapy safe in the perioperative period? To answer this question, Dr. Peter Buch is joined by Drs. Benjamin Cohen and Stefan Holubar from the Cleveland Clinic to discuss the findings from the PUCCINI study.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Victoria Gomez, MD

Endoscopic sleeve gastroplasty may be an effective option for weight loss. But which of our patients are the right candidates—and what do they need to know about before and after the procedure? Dr. Peter Buch dives into this procedure with Dr. Victoria Gomez, an Associate Professor of Medicine at the Mayo Clinic in Florida.

Host: John Russell, MD
Guest: Paul Craddock, PhD

Beginning in the mid-16^th century up until present day, medicine has evolved tremendously. How did transplant surgery play an important role in doing so? Dive into the teachings with Dr. Paul Craddock, author of the book titled, Spare Parts: The Story of Medicine Through the History of Transplant Surgery, as he joins Dr. John Russell to dissect the surprising history of modern medicine.

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Nick Kusnezov, MD

Can you balance locum tenens with a full-time career? To answer that question, Dr. Charles Turck is joined by board-certified orthopedic surgeon, Dr. Nicholas Kusnezov, to walk us through his journey from joining the military to locum tenens.

Host: Matthew Sorrentino, MD
Guest: Javed Butler, MD, MBA, MPH

In a groundbreaking procedure, a 57-year-old man with life-threatening heart disease received a heart from a genetically altered pig. Surgeons at the University of Maryland Medical Center performed the 8-hour operation, making it the first successful transplant of a pig's heart into a human being. And while much is still uncertain, what could this achievement mean for the future of organ transplantation? That’s what ReachMD hosts Dr. Matthew Sorrentino and Dr. Javed Butler explore together.

Please note: Since the date of publication, David Bennet, the patient who received a heart transplant from a pig, died at the age of 57 at the University of Maryland Medical Center on March 8, 2022.